Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
Viruses. 2020 Dec 26;13(1):29.
Viruses. 2020 Dec 26;13(1):29.
Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Molecular Diagnosis of COVID-19: Challenges and Research Needs
Nonessential Research in the New Normal: The Impact of COVID-19
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
COVID-19 and emerging viral infections: The case for interferon lambda
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus